Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Infectious Diseases
Volume 12, Issue 2, Pages 89-92
http://dx.doi.org/10.1155/2001/758483
Original Article

Initial Drug Regimen for Active Tuberculosis Cases in Montreal, 1995-1998

Paul Rivest1 and Terry N Tannenbaum1,2

1Direction de la santé publique, Régie régionale de la santé et des services sociaux de Montréal-Centre, Canada
2Joint Departments of Occupational Health and Epidemiology & Biostatistics, McGill University, Montreal, Québec, Canada

Received 31 May 1999; Accepted 18 March 2000

Copyright © 2001 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

OBJECTIVES: To evaluate the proportion of tuberculosis (TB) cases initially treated with the recommended four-drug regimen of isoniazid (INH), rifampin (RIF), pyrazinamide (PZA) and ethambutol (EMB) or streptomycin; and to identify factors associated with the choice of initial therapy.

DESIGN: Descriptive analysis of surveillance data obtained by TB case notifications from physicians and microbiology laboratories.

SETTING: The island of Montreal (with a population of 1,854,435 people).

STUDY POPULATION: All TB cases reported between January 1, 1995 and December 31, 1998.

OUTCOME MEASURE: The proportion of TB cases initially treated with a four-drug regimen by sex, age, country of birth, site of disease and year of reporting.

MAIN RESULTS: Seven hundred forty-one cases were reported during the study period. Among the 687 analyzed cases, 406 (59.1%) received the recommended initial four-drug regimen (INH-RIF-PZA-EMB), 187 (27.2%) received an INH-RIF-PZA regimen, 61 (8.9%) received an INH-RIF-EMB regimen and 33 (4.8%) received an INH-RIF regimen only. In a logistical regression model, a four-drug regimen was significantly associated with respiratory disease (odds ratio [OR] 4.48; 95% CI 3.15 to 6.39), age younger than 65 years (OR 2.32; 95% CI 1.55 to 3.45), being foreign-born (OR 1.62; 95% CI 1.06 to 2.48) and later year of reporting (OR 1.27; 95% CI 1.09 to 1.47).

CONCLUSIONS: The proportion of TB cases initially treated with a four-drug regimen has increased steadily since 1995, reaching 65% in 1998. However, given the rate of INH resistance in Montreal, efforts to promote the use of the initial four-drug regimen must continue.